Journal Home
Search for

Volume 14, Issue 2, Pages 82-88 (April 2004)


View previous. 7 of 17 View next.

Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study

Part of this report was presented in abstract form at the World Congress of Nephrology in Berlin, June, 2003.

Stanisław Czekalski, MD, PhDCorresponding Author Informationemail address, Roman Hożejowski, MD, Malnutrition Working Group

Abstract 

Objective

Prospective evaluation of the effect of 6-month-long intradialytic amino acids (AA) supplementation on selected nutritional variables in malnourished hemodialysis (HD) patients.

Design

Multicenter, prospective, (nonrandomized, noncontrolled) observational study.

Setting

Thirty-one HD units affiliated with academic centers and tertiary-care hospitals.

Patients

Adult patients treated by HD for at least 6 months. Inclusion criteria were: serum albumin concentration ≤39 g/L and at least 4% loss of body weight during the last 6 months in otherwise stable HD patients. From a cohort of 133 patients who were enrolled, 97 (54 men and 43 women) were eligible for the analysis.

Intervention

Intradialytic AA supplementation with 500 mL 10% solution per HD session for a period of 6 months.

Main outcome measures

Serum albumin concentration, modified Subjective Global Assessment (SGA) score, body mass index (BMI), mid-arm circumference (MAC), and total lymphocyte count. Measurements were recorded at baseline and after 3 and 6 months of AA supplementation.

Results

Serum albumin concentration increased significantly from the mean 32.5 ± 4.6g/L at baseline to 36.4 ± 4.8 g/L at 3 months (P < .001) and 37.1 ± 4.8g/L at final observation (P < .001 versus baseline). Significant correlation was observed between frequency of AA supplementation and serum albumin increase (r = 0.41; P < .0001). Rate of improvement negatively correlated significantly with baseline concentration of serum albumin (r = − 0.42; P < .0001). SGA score significantly improved from median of 16 points at baseline to 12 points at 3 months (P < .01) and 11 points at 6 months (P < .01 versus baseline), and this improvement also correlated with the frequency of AA supplementation. Small yet significant increase of MAC was observed at 6 months (from baseline 24.1 ± 4.3 to 24.8 ± 4.8 cm; P < .01), whereas BMI remained unchanged.

Conclusion

Intradialytic AA supplementation improves selected nutritional parameters of HD patients with malnutrition. The improvement depends on the intensity of supplementation.

 Professor of Medicine, Head of Chair and Department of Nephrology, Transplantology and Internal Diseases, University of Medical Sciences, Poznań, Poland

 Medical Manager, Medical Department, Fresenius Kabi Poland, Warsaw, Poland

Corresponding Author InformationAddress reprint requests to Stanisław Czekalski, MD, PhD, Department of Nephrology, Transplantology and Internal Diseases, Prof. Stanisław Czekalski ul. Przybyszewskiego 49, 60-355 Poznań, Poland

 Supported in part by a grant from Fresenius Kabi, Poland.

PII: S1051-2276(04)00008-1

doi:10.1053/j.jrn.2004.01.007


View previous. 7 of 17 View next.